Technology
Business
Medical
Healthcare
manufacturing
Aerospace
Defence
Industrial
Electronics Manufacturing
Mechanical Manufacturing
Lifesciences
Cyient DLM Investor Presentation Summary🚨
Cyient DLM is an electronics and mechanical manufacturing partner and systems supplier to some of the largest players across multiple industries. It caters to the needs of various sectors like Aerospace & Defence, Medical and Lifesciences, Industrial
Under Aerospace and defence, some of the products manufactured are Cockpit Display Units, Flight Management System, Surveillance Radar System, Communication/Navigation Systems, Radar Sensors and RF Products. Other expertise includes Box Build Integration, Wire Harness, PCB Assembly, Precision Tooling etc.
Under Medical and Lifesciences segment, company offers Non-invasive medical devices, patient monitoring systems, diagnostic equipments, ultrasound imaging systems, X-Ray/MRI Subsystems.
Under industrial segment, company focusses on Building technology, Clean Energy Products, Smart Meters, Flow Measurement and Analysis Units, Room and Plant Controllers.
Under industrial segment, company focusses on Building technology, Clean Energy Products, Smart Meters, Flow Measurement and Analysis Units, Room and Plant Controllers.
In FY24, company inaugurated new precision machining facility in Banglore with 36000+sq. ft. of manufacturing area.
It also inaugurated manufacturing facility in Mysuru which strengthen its existing capabilities.
It also inaugurated manufacturing facility in Mysuru which strengthen its existing capabilities.
Revenue recorded by the company increased by 31% from 277Cr in Q4FY23 as compared to 362Cr in Q4FY24.
Whereas PAT increased by 81% from 13Cr to 23Cr during the same time period.
Whereas PAT increased by 81% from 13Cr to 23Cr during the same time period.
Of the total revenue in Q4FY24, 56% of the shares contribute to Aerospace, 25 % contribute to Defence, 9% to industrial, 8% to med tech and 2% to Rail.
Also, of the total revenue in Q4FY24, 34% came from the domestic market while, 66% came from exporting to other countries.
Also, of the total revenue in Q4FY24, 34% came from the domestic market while, 66% came from exporting to other countries.
Company is looking forward to strengthen its B2S offerings. It is also targeting Inorganic expansion for which it will strategize client proximity and geographic footprint, accessing target clients and expanding its clients.
Also, the company is looking forward to tap growing EMS destinations and strategize entering disruptive industries like Electric Vehicle and 5G.
This is not a BUY or SELL recommendation. It is only for information purpose.
Ensure a thorough analysis of risks and opportunities before making any decision.
For more such information,
Follow ❤️@sovrennofficial
Please Retweet for Maximum Reach.
Ensure a thorough analysis of risks and opportunities before making any decision.
For more such information,
Follow ❤️@sovrennofficial
Please Retweet for Maximum Reach.
Try Sovrenn.com ABSOLUTELY FREE and experience the power of small cap and microcap investing
We must study the following types of companies thoroughly. Going through such data also helps in finding good investments:
1. Companies posting excellent results in the March’24 quarter: sovrenn.com
2. Companies doing preferential equity allotment and raising growth capital: sovrenn.com
3. Companies doing capital expenditure and increasing the fixed asset base: sovrenn.com
4. Companies doing JVs and acquisitions: sovrenn.com
5. Companies being purchased by other smart investors: sovrenn.com
6. Companies getting large orders: sovrenn.com
1. Companies posting excellent results in the March’24 quarter: sovrenn.com
2. Companies doing preferential equity allotment and raising growth capital: sovrenn.com
3. Companies doing capital expenditure and increasing the fixed asset base: sovrenn.com
4. Companies doing JVs and acquisitions: sovrenn.com
5. Companies being purchased by other smart investors: sovrenn.com
6. Companies getting large orders: sovrenn.com
Loading suggestions...